跳至主要内容
临床试验/NCT02377440
NCT02377440已完成不适用

Effects of Angiotensin Converting Enzyme Inhibitors (ACEI) on Bone Turnover

The University of Texas Health Science Center, Houston2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
2
主要终点
Change in serum CTX levels in pg/mL

研究概览

简要总结

The investigators hypothesize that older persons (≥45 years) treated with ACEI for HTN control will have: i) improved status of bone turnover (decreased P1NP and CTX), and ii) decreased levels of RANKL and RANKL/OPG, compared to those not treated with ACEI and not using RAS-related medications

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • at least 45 years of age
  • a diagnosis of (either new or uncontrolled) HTN who will need a new medication for HTN control
  • able to consent (no medial issues impairing judgment for consenting based on clinical providers' judgment).

排除标准

  • younger than 45 years of age
  • a diagnosis of metabolic bone disease
  • a diagnosis of osteoporosis or use of medication to treat osteoporosis
  • a diagnosis of diabetes mellitus, or renal insufficiency, or cancer
  • history of allergy to ACEI or ARB, 6) history of use of ACEI or ARB.

结局指标

主要结局

Change in serum CTX levels in pg/mL

时间窗: baseline, 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nahid Rianon

Assistant Professor

The University of Texas Health Science Center, Houston

研究点 (2)

Loading locations...

相似试验